Stryker Corporation (SYK)
| Market Cap | 90.30B |
| Revenue (ttm) | 14.35B |
| Net Income (ttm) | 1.60B |
| Shares Out | 375.50M |
| EPS (ttm) | 4.20 |
| PE Ratio | 57.15 |
| Forward PE | 26.67 |
| Dividend | $2.36 |
| Dividend Yield | 0.98% |
| Trading Day | March 5 |
| Last Price | $240.03 |
| Previous Close | $235.80 |
| Change ($) | 4.23 |
| Change (%) | 1.79% |
| Day's Open | 237.58 |
| Day's Range | 232.58 - 241.24 |
| Day's Volume | 1,617,562 |
| 52-Week Range | 123.01 - 250.02 |
Kalamazoo, Michigan, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021.
KALAMAZOO, Mich., Feb. 16, 2021 /PRNewswire/ -- C2Dx Inc., a medical device company that invests in and refines the delivery of valuable, niche products to propel their growth, has acquired th...
Kalamazoo, Michigan, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable April 30, 2021 to s...
Stryker's (SYK) fourth-quarter earnings reflect strong segmental performance.
Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2020 Results - Earnings Call Transcript
Stryker (SYK) delivered earnings and revenue surprises of 10.20% and -0.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Stryker (NYSE:SYK) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 12.85% over the past year to $2.81, which b...
Kalamazoo, Michigan, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook:
On Wednesday, January 27, Stryker (NYSE:SYK) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Stryker's (SYK) fourth-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.
The robotics sector looks poised for a turnaround given the rapid shift to digitization and automation, making it wise to keep an eye on names like iRobot (IRBT), Ambarella (AMBA) and Stryker ...
Stryker's (SYK) acquisition of OrthoSensor will help surgeons with real-time data-driven solutions and improve patient outcomes.
Robotics stocks are poised to grow in 2021, calling for investment in Trimble (TRMB), Rockwell Automation (ROK), ReWalk Robotics (RWLK), Fanuc Corp (FANUY) and Stryker (SYK).
Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss th...
Stryker Corporation is a Dividend Champion with 27 consecutive years of dividend growth. Shares currently yield 1.03%. Stryker Corporation is poised to benefit from an aging and active populat...
Investors like keeping an eye on the famed investor Buffett. Here are seven more companies that could possibly become Warren Buffett stocks.
Dividend Changes: December 19-25, 2020
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Stryker Corp. (NYSE:SYK) is in the right place with the right portfolio of products and the right strategy to continue its winning streak on Wall Street.
Disappointing jobless data combined with no stimulus and a pandemic continuing to reach grim records caused markets to trade largely mixed today. For investors looking to make the most of this...
Stryker Corporation (SYK) Presents at Evercore ISI Third Annual HealthCONx Conference - Conference Call Transcript
Stryker Corp. said late Wednesday that its board of directors has declared a quarterly dividend of 63 cents a share, payable Jan. 29 to shareholders of record at the close of business on Dec. ...
Kalamazoo, Michigan, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable January 29, 2021 to...
I was optimistic with my dividend growth predictions for the last two weeks of November. Notably, Sysco held their dividend steady and Tyson Foods – from which I had expected a double digit bo...
Kalamazoo, Michigan, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) (the “Company”) announced today that it has priced an offering of $600 million aggregate principal amount of its 0.600...
Kalamazoo, Michigan, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Thursday, December 3, 2020.
Shares of Stryker Corp. (NYSE:SYK) are up 10.5% in 2020, but almost the entirety of that gain has been since the company reported earnings results at the end of October. Covid-19 has negativel...
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Colfax (CFX) arm DJO closes buyout of products/system related to ankle replacement and finger arthroplasty from Stryker, which will boost its product offerings in the reconstructive products s...
Kalamazoo, Michigan, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI...
Kalamazoo, Michigan, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuati...
Kalamazoo, Michigan, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Giovanni Caforio, M.D., Chairman and Chief Executive Officer of Bristol Myers Squibb, has been el...
Kalamazoo, Michigan, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for the previously announced cash tender of...
In this article we are going to use hedge fund sentiment as a tool and determine whether Stryker Corporation (NYSE:SYK) is a good investment right now. We like to analyze hedge fund sentiment ...
Final Trades: Honeywell, Stryker, & more
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker's (SYK) third-quarter earnings reflect strong segmental performance.
Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2020 Results - Earnings Call Transcript
Stryker (SYK) delivered earnings and revenue surprises of 52.86% and 9.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Stryker (NYSE:SYK) decreased 1.75% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 12.04% year over year to $2.14, which b...
Kalamazoo, Michigan, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2020:
Stryker's (SYK) third-quarter results are likely to reflect weak segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Kalamazoo, Michigan, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period ...
Stryker (SYK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Let's keep a watch on potentially strong three MedTech stocks with respect to robotic-assisted surgery that have shown promise during the pandemic.
While technology has been the engine that has driven stock market performance for some time now, increasingly we are seeing a seismic shift to health care among many portfolio managers, and wi...
LEESBURG, Va.--(BUSINESS WIRE)--Stryker marks one million Mesa Pedicle Screw Implantations globally, and will virtually showcase Mesa at the NASS annual meeting, Oct. 6-9.
About SYK
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other me... [Read more...]
| Industry Medical Devices | Founded 1941 |
| CEO Kevin Lobo | Employees 43,000 |
| Stock Exchange NYSE | Ticker Symbol SYK |
Financial Performance
In 2020, Stryker's revenue was $14.35 billion, a decrease of -3.58% compared to the previous year's $14.88 billion. Earnings were $1.60 billion, a decrease of -23.24%.
Analyst Forecasts
According to 30 analysts, the average rating for Stryker stock is "Buy." The 12-month stock price forecast is 252.17, which is an increase of 5.06% from the latest price.